Indian Journal of Nuclear Medicine

CASE REPORT
Year
: 2014  |  Volume : 29  |  Issue : 4  |  Page : 252--253

Positron emission tomography/computerized tomography imaging of multiple focus of neurolymphomatosis


James Peterson1, Billur Caliskan2, Shahram Bonyadlou1,  
1 Department of Radiology, Division of Nuclear Medicine, Keck Medical Center, Keck School of Medicine University of Southern California, Los Angeles, California, USA
2 Department of Nuclear Medicine, Faculty of Medicine, Abant Izzet Baysal University, Nukleer Tip AD, Bolu 14280, Turkey

Correspondence Address:
Billur Caliskan
Department of Nuclear Medicine, Faculty of Medicine, Abant Izzet Baysal University, Nukleer Tip AD, Bolu 14280
Turkey

Abstract

Neurolymphomatosis is defined as infiltration of the peripheral nervous system by malignant lymphocytes in the presence of lymphoma. In this case, we described multiple neurol involvement and findings of 18 F-fluorodeoxyglucose positron emission tomography/computerized tomography in a 35-year-old female diagnosed with B-cell lymphoma.



How to cite this article:
Peterson J, Caliskan B, Bonyadlou S. Positron emission tomography/computerized tomography imaging of multiple focus of neurolymphomatosis.Indian J Nucl Med 2014;29:252-253


How to cite this URL:
Peterson J, Caliskan B, Bonyadlou S. Positron emission tomography/computerized tomography imaging of multiple focus of neurolymphomatosis. Indian J Nucl Med [serial online] 2014 [cited 2022 Oct 2 ];29:252-253
Available from: https://www.ijnm.in/text.asp?2014/29/4/252/142632


Full Text

 INTRODUCTION



Neurolymphomatosis (NL) is defined as infiltration of the cranial nerves, peripheral nerves, nerve roots, or plexus by malignant lymphocytes in the presence of lymphoma and remains a rare cause of peripheral neuropathy. It can also involve the cerebro-spinal fluid, brain and spinal cord. [1] Histopathologic involvement of NL is characterized by tumor cell infiltration of the endoneurium and perineurium. The B-cell type of non-Hodgkin lymphoma tends to be the predominant type involving the peripheral nerves. NL tends to occur with aggressive subtypes such as diffuse large B-cell lymphoma and has a variable response to current therapeutic treatments, carrying a poor prognosis. It is most common in patients who relapse, secondarily presenting solely with neurolympomatosis despite ongoing complete remission at original or other sites outside the nervous system. It presents clinically with varying degrees of peripheral neuropathy. On imaging, it is most often demonstrated by diffuse or nodular nerve root or nerve sheath thickening, and sometimes, though very rare, a mass like appearance. [2],[3]

 CASE REPORT



In this case, we described multiple neural involvement and findings of fluorodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT) in a 35-year-old female diagnosed with diffuse stage IV large B-cell lymphoma, originally diagnosed in April 2013, involving the stomach, duodenum, pancreas, kidneys, and epicardium of the heart. The patient received two cycles of rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone chemotherapy, and intrathecal methotrexate. She presented 3 months later with neurological changes including blurry vision, cranial nerve VI palsy with diplopia, photophobia, left lower facial droop, right upper extremity weakness, including right wrist and hand weakness, and right leg pain. She reported having mild imbalance during walking with intermittent fevers and night sweats.

Positron emission tomography/CT demonstrated multiple areas of increased metabolic activity along several diffusely enlarged nerves, most significant along the left trigeminal nerve distribution, including V1 through V3 and near the left mandible and left tongue base [Figure 1]. Involvement within the right C7 nerve root and its distal right musculocutaneous nerve distribution was also identified. There was involvement of the bilateral sciatic nerves with extension distally along the left distal left femoral nerve near the popliteal fossa [Figure 2]. These findings were consistent with NL. In addition, there was questionable involvement of the cranial nerve XII on the right.{Figure 1}{Figure 2}

 DISCUSSION AND CONCLUSION



Neurolymphomatosis as defined by lymphomatous involvement of peripheral and cranial nerves remains rare. This usually develops in patients with nonHodgkin's lymphoma, often presenting after remission, with its sole re-presentation within the neurologic system. It may present clinically as painful polyneuropathy or polyradiculopathy, followed by cranial neuropathy, painless polyneuropathy and peripheral mononeuropathy. [1],[2],[4] Of note, most of the lymphomatous involvement of peripheral nerves described in the literature involves the sciatic nerve. [5] It is described during or following chemotherapy with good response to the original presenting systemic disease. Most case reports demonstrate diffuse or solitary thickening of the nerves/nerve sheath and nerve roots, and rarely, as a mass. [6],[7],[8] The differential considerations are Gillian Barrι syndrome, herpes zoster, demyelinating polyradiculoneuropathy, vinca alkaloid toxicity, mechanical compression of nerve roots, and systemic amyloidosis. [2] In diagnosis of NL the sensitivity of nerve biopsies was 80%, of MRI was 40% and cerebrospinal fluid examination was 21%. [2]

During the progressive disease or therapy following aggressive lymphoma, peripheral neuropathy may be difficult to distinguish and the differential, particularly given the patient's immune compromised state, remains broad. NL fortunately remains rare as it carries a poor prognosis. However, PET/CT is useful diagnostic tool in the evaluation and follow-up of the patient's, often sufficient for diagnosis in the appropriate clinical setting, with characteristic neuroimaging findings; primarily demonstrated by diffuse or nodular nerve root or nerve sheath thickening, and rarely, a mass like appearance.

References

1Agrawal S, Gi MT, Ng SB, Puhaindran ME, Singhania P. MRI and PET-CT in the diagnosis and follow-up of a lymphoma case with multifocal peripheral nerve involvement. Diagn Interv Radiol 2013;19:25-8.
2Gan HK, Azad A, Cher L, Mitchell PL. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neuro Oncol 2010;12:212-5.
3Boasquevisque GS, Guidoni J, de Souza LA, Goncalves PG, Andrade CV, Pedras FV, et al. Bilateral vagus nerve neurolymphomatosis diagnosed using PET/CT and diffusion-weighted MRI. Clin Nucl Med 2012;37:e225-8.
4Baehring JM, Batchelor TT. Diagnosis and management of neurolymphomatosis. Cancer J 2012;18:463-8.
5Gonzalvo A, McKenzie C, Harris M, Biggs M. Primary non-Hodgkin's lymphoma of the radial nerve: case report. Neurosurgery 2010;67:E872-3.
6Guo H, Mosci C, Iagaru A. Demonstration of peripheral nerve root involvement by non-Hodgkin's lymphoma on 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging 2012;39:729-30.
7Bronstein Y, Tummala S, Rohren E. F-18 FDG PET/CT for detection of malignant involvement of peripheral nerves: Case series and literature review. Clin Nucl Med 2011;36:96-100.
8Salm LP, Van der Hiel B, Stokkel MP. Neurolymphomatosis diagnosed by (18) F-FDG PET-CT. Clin Nucl Med 2013;38:e261-2.